Pharma Deals Review, Vol 2007, No 83 (2007)

Font Size:  Small  Medium  Large

KV Acquires Rights to Menopause Transdermal Spray

Business Review Editor

Abstract


KV entered into agreement with VIVUS to acquire US marketing rights to EvaMist™, which is phase 3 clinical trials for treating vasomotor symptoms associated with menopause.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.